Peter H. O'Donnell to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Peter H. O'Donnell has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.222
-
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO Precis Oncol. 2023 07; 7:e2300095.
Score: 0.222
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.